Neutrophil gelatinase associated lipocalin is an independent predictor of poor prognosis in cases of papillary renal cell carcinoma

Journal of Urology

Volumn 194, Issue 3, 2015, Pages 647-652

  Zhang, Mingxin ^a   Zhao, Xiaozhi ^a   Deng, Yongming ^a   Tang, Bo ^b   Sun, Qi ^a   Zhang, Qing ^a   Chen, Wei ^a   Yao, Dongwei ^a   Yang, Jun ^a   Cao, Lin ^c   Guo, Hongqian ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Vazyme Biotech Co   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

carcinoma; human; LCN2 protein; prognosis; renal cell; survival

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY INJURY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHRON SPARING SURGERY; OVERALL SURVIVAL; PAPILLARY RENAL CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; BIOSYNTHESIS; CHEMISTRY; KIDNEY TUMOR; METABOLISM; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ACUTE-PHASE PROTEINS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIPOCALINS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84938977630     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.04.080     Document Type: Article

References (30)

1. P. Devarajan Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease Scand J Clin Lab Invest Suppl 241 2008 89
2. D.H. Goetz, M.A. Holmes, N. Borregaard, and et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Mol Cell 10 2002 1033
3. J.A. Gwira, F. Wei, S. Ishibe, and et al. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro J Biol Chem 280 2005 7875
4. J. Yang, D. Goetz, J.Y. Li, and et al. An iron delivery pathway mediated by a lipocalin Mol Cell 10 2002 1045
5. M. Bauer, J.C. Eickhoff, M.N. Gould, and et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer Breast Cancer Res Treat 108 2008 389
6. M.F. Liu, T. Jin, J.H. Shen, and et al. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis J Neurooncol 104 2011 119
7. Z. Tong, A.B. Kunnumakkara, H. Wang, and et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Res 68 2008 6100
8. R. Lim, N. Ahmed, N. Borregaard, and et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition Int J Cancer 120 2007 2426
9. X.F. Zhang, Y. Zhang, X.H. Zhang, and et al. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) expression in primary rectal cancer BMC Cancer 9 2009 134
10. L.R. Devireddy, C. Gazin, X. Zhu, and et al. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake Cell 123 2005 1293
11. M. Bjorklund, and E. Koivunen Gelatinase-mediated migration and invasion of cancer cells Biochim Biophys Acta 1755 2005 37
12. L. Yan, N. Borregaard, L. Kjeldsen, and et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL J Biol Chem 276 2001 37258
13. S. Lee, S.M. Jilani, G.V. Nikolova, and et al. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors J Cell Biol 169 2005 681
14. V. Barresi, A. Ieni, D. Bolignano, and et al. Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade Oncol Rep 24 2010 305
15. A. Friedl, S.P. Stoesz, P. Buckley, and et al. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression Histochem J 31 1999 433
16. B. Delahunt, and J.N. Eble Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors Mod Pathol 10 1997 537
17. S. Toyokuni Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Sci 100 2009 9
18. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 1982 655
19. S.B. Edge, D.R. Byrd, C.C. Compton, and et al. AJCC Cancer Staging Manual 7th ed. 2010 Springer-Verlag New York
20. S. Candido, R. Maestro, J. Polesel, and et al. Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer Oncotarget 5 2014 1576
21. G. Lippi, T. Meschi, A. Nouvenne, and et al. Neutrophil gelatinase-associated lipocalin in cancer Adv Clin Chem 64 2014 179
22. A. Iannetti, F. Pacifico, R. Acquaviva, and et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells Proc Natl Acad Sci U S A 105 2008 14058
23. H. Cho, and J.H. Kim Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer J Histochem Cytochem 57 2009 513
24. C.A. Fernandez, L. Yan, G. Louis, and et al. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients Clin Cancer Res 11 2005 5390
25. A. Szponar, D. Zubakov, J. Pawlak, and et al. Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression Int J Cancer 124 2009 2071
26. J. Yang, K. Mori, J.Y. Li, and et al. Iron, lipocalin, and kidney epithelia Am J Physiol Renal Physiol 285 2003 F9
27. M. de Martino, A.J. Pantuck, S. Hofbauer, and et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma J Urol 190 2013 1999
28. G. Giuffre, V. Barresi, C. Skliros, and et al. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas Oncol Rep 17 2007 1021
29. J.J. Morrissey, A.N. London, M.C. Lambert, and et al. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma Am J Nephrol 34 2011 391
30. C. Porta, C. Paglino, M. De Amici, and et al. Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib Kidney Int 77 2010 809